Blog
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Biogen's (NASDAQ: BIIB) Alzheimer's disease drug Aduhelm has been embroiled in controversy for a while. Now, there are reports that the drug could have some potentially serious safety issues. In
Should Zoom Acquire Bandwidth Instead of Five9?
Zoom Video Communications (NASDAQ: ZM) and Five9 (NASDAQ: FIVN) recently called off their merger. But speculation has arisen that perhaps Zoom would be interested in acquiring Bandwidth (NASDAQ:
Got $5,000? Buy These 2 Fast-Growing Stocks on the Dip
Since the start of September, the S&P 500 has fallen by more than 2.5%. And many top growth stocks have been falling along with the index. Although it may be a bit unnerving to buy into this dip
The New Product to Help Salesforce.com Get Ahead of the Curve
Back when Salesforce.com (NYSE: CRM) first began operations, there weren't any public cloud vendors around. Now that they're so widely used around the world, Salesforce has developed a new
3 Red-Hot Stocks That Could Continue to Beat the Market
Let's face it; September stunk for most investors. The three major U.S. indexes were down for the month, and many growth stocks experienced even sharper declines. But it's not all bad; some stocks
Are Today's Workers Dramatically Underestimating the Cost of Retirement?
The average worker believes they'll need about $500,000 to feel financially secure in retirement, according to a Transamerica survey. But there's a wide variance in opinion by generation. The median
Why Cloudflare Stock Is Jumping This Week
Shares of edge network software specialist Cloudflare (NYSE: NET) are surging this week. At its highest point during the week, the growth stock was up 19.2%. As of the market close on Thursday, the
5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter
If you've ever wondered why Wall Street and retail investors pay such close attention to billionaire Warren Buffett, it's because he has an impeccable moneymaking track record.
Since taking over as
Is an Acquisition of Acceleron a Smart Move for Merck?
First, there were rumors that Merck (NYSE: MRK) might acquire Acceleron Pharma (NASDAQ: XLRN). Then those rumors were confirmed, with the big pharma company announcing plans to buy Acceleron for
The High-Growth Microcap Stock Wall Street Is Sleeping On
Casper Sleep (NYSE: CSPR) is keeping investors up at night after a disappointing second-quarter earnings report sent shares tumbling. The stock is still falling two months after its financials were
3 Top Stocks to Buy if the Market Crashes
Every crisis presents an opportunity. For investors, substitute "stock market crash" for "crisis."
Don't get me wrong. I'm by no means predicting that the stock market is going to crash anytime
3 Unstoppable Stocks to Buy in October
Don't let the volatility we've seen in recent days rattle you. Sure, quite a few stocks have pulled back. But for many of them, their underlying businesses are as strong as ever. The sell-off of
The Smartest Stocks to Buy With $100 Right Now
Patience pays off handsomely when investing in the stock market. Despite navigating our way through the quickest decline of at least 30% in the S&P 500's history during the first quarter of 2020
Where to Invest $10,000 Right Now
If you have $10,000 to invest this month, you're likely looking for a few high-quality businesses to put that money into that can fuel generous returns for the long haul. With such a solid amount of
Where to Invest $1,000 Right Now
If you have $1,000 to invest this month, you're probably on the hunt for more great stocks that can generate long-term portfolio returns. The great news is that you don't have to look far to find
Accolade, Inc. (ACCD) Q2 2022 Earnings Call Transcript
Image source: The Motley Fool.
Accolade, Inc. (NASDAQ: ACCD)Q2 2022 Earnings CallOct 07, 2021, 4:30 p.m. ET
Operator
Source Fool.com
3 Stock Market Myths That Cost Investors
"The stock market is filled with individuals who know the price of everything, but the value of nothing." -- Philip Fisher, Investor and Author
More people have access to the stock market than ever
3 Social Security Strategies to Bankroll Your Retirement
Whether Social Security ends up representing the bulk of your retirement income or just a portion of it, it's important to get as much out of the program as you can. And if you expect your benefits
Tilray, Inc. (TLRY) Q1 2022 Earnings Call Transcript
Image source: The Motley Fool.
Tilray, Inc. (NASDAQ: TLRY)Q1 2022 Earnings CallOct 07, 2021, 8:30 a.m. ET
Operator
Source Fool.com
The United States Avoids Default... For At Least Two Months
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Treasury
Walmart Charters Its Own Cargo Ships to Skirt Port Traffic Jams
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Before Covid, it
Saudi-led Group Scores English Premier League's Newcastle United Soccer Team
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
With just five
Park Aerospace Corp (PKE) Q2 2022 Earnings Call Transcript
Image source: The Motley Fool.
Park Aerospace Corp (NYSE: PKE)Q2 2022 Earnings CallOct 7, 2021, 11:00 a.m. ET
Operator
Source Fool.com
These 2 COVID-19 Stocks Could Boost the Market Friday
The stock market continued to gain ground on Thursday, picking up greater momentum as investors started to get more comfortable with the idea of a full economic recovery. Even with bond yields
Why Hexo, Tilray, Canopy Growth, and Sundial Stocks Are Glowing Green Today
Marijuana stocks are growing like weeds (pardon the pun) on Thursday. As of 2:40 p.m. EDT, Hexo (NASDAQ: HEXO) stock has risen 2.4% and Tilray (NASDAQ: TLRY) shares are up 2.9%. Canopy Growth